查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1376219

葡萄糖胺市场规模、份额、趋势分析报告：按产品、按应用、按地区、细分市场预测，2023-2030

Glucosamine Market Size, Share & Trends Analysis Report By Product (Glucosamine Sulfate, Glucosamine Hydrochloride, N-acetyl Glucosamine, Others), By Application (Supplement, Food & Beverages), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 70 Pages | 商品交期: 2-10个工作天内

价格

葡萄糖胺市场成长与趋势：

Grand View Research, Inc. 的最新报告显示，到 2030 年，全球葡萄糖胺市场预计将达到 13.098 亿美元。

预计2023年至2030年年复合成长率为5.2%。扩大该食品在营养补充生产中的应用，以帮助消费者预防骨关节炎，预计在未来年度推动需求。

素食消费者数量的增加，特别是在包括美国在内的已开发国家，预计将成为预测期内该行业的另一个驱动因素。该产品主要由虾和蟹等甲壳类动物製成，但嘉吉和 Cyanotech 透过从真菌黑曲菌中提取成分，率先推出了素食葡萄糖胺。

人口增长、医疗保健行业的快速增长以及消费者对关节和骨骼健康的认识预计将推动葡萄糖胺在各种食品和饮料中的使用。此外，对欧洲食品和饮料製造产品使用法规结构的支持预计也将推动未来年度的产业成长。然而，鱼油和含 omega-3替代的增加可能会对预测期内的产品需求造成挑战。

葡萄糖胺市场报告亮点

  • 2022 年，葡萄糖胺硫酸盐业务占最大收益占有率，达到 61.1%。硫酸盐葡萄糖胺是营养补充和食品中最广泛使用的葡萄糖胺型态之一。
  • 盐酸葡萄糖胺业务预计在预测期内将以 5.2% 的复合年复合成长率成长，位居第二。盐酸葡萄糖胺是一种常用作食品营养补充以支持关节健康的化合物。
  • 2022 年，补充剂行业占据最大的销售份额，达到 79.9%。这些补充剂主要由贝类製成，包括虾和蟹，但随着过敏案例的增加和素食者数量的增加，尤其是在美国，製造商正在用真菌和其他植物来源生产产品。我们正在开始开发产品。
  • 亚太地区占据市场主导地位，2022 年占最大销售份额，达 47.9%。亚太地区包括中国、日本、印度和澳洲等国家，人口众多且扩张迅速，全部区域的健康和保健意识也正在快速提高。

目录

第1章调查方法和范围

第2章执行摘要

第3章葡萄糖胺市场变数、趋势、范围

  • 市场体系展望
  • 普及和成长前景图
  • 价值链分析
  • 法律规范
  • 市场动态
    • 市场驱动因素分析
    • 市场抑制因素分析
    • 产业机会与挑战
  • 葡萄糖胺市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第4章供应商组合分析

  • 供应商名单
  • Kraljic Matrix
  • 采购最佳实践
  • 谈判策略

第5章葡萄糖胺：产品估算与趋势分析

  • 葡萄糖胺市场：要点
  • 葡萄糖胺市场：2022 年和 2030 年趋势和市场占有率分析
  • 葡萄糖胺硫酸盐
  • 盐酸葡萄糖
  • N-乙酰葡萄糖胺
  • 其他的

第6章葡萄糖胺：使用量估算与趋势分析

  • 葡萄糖胺市场：要点
  • 葡萄糖胺市场：2022 年和 2030 年趋势和市场占有率分析
  • 补充
  • 食品与饮品
  • 其他的

第7章葡萄糖胺市场：区域估计与趋势分析

  • 区域展望
  • 按地区分類的葡萄糖胺市场：要点
  • 北美洲
    • 2018-2030 年市场估计与预测
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
  • 亚太地区
    • 日本
    • 中国
    • 印度
  • 中美洲和南美洲
    • 巴西
  • 中东/非洲
    • 沙乌地阿拉伯
    • 南非

第8章竞争形势

  • 主要市场参与企业的最新趋势和影响分析
  • 市场参与企业分类
    • Koyo Chemical Industry Co., Ltd
    • Laboratoires Expanscience
    • Nutramax Laboratories Consumer Care, Inc.
    • Amway
    • CELLMARK AB.
    • Alfa Chemical Group
    • Cargill, Incorporated
    • Dalian Lijian Bio-Technology Development Co. Ltd
    • SimplySupplements
Product Code: 978-1-68038-091-0

Glucosamine Market Growth & Trends:

The global glucosamine market is expected to reach USD 1309.8 million by 2030, according to a new report by Grand View Research, Inc.. It is expected to expand at a CAGR of 5.2% from 2023 to 2030. The growing application scope of the product in the manufacturing of nutritional supplements, which aid in the prevention of osteoarthritis among consumers is expected to fuel demand over the next seven years.

An increasing number of vegan consumers particularly in developed countries including the U.S. is expected to be another driver for the industry over the forecast period. The product is primarily manufactured from crustaceans including shrimp and crab; however, Cargill and Cyanotech have pioneered vegetarian glucosamine by extracting the ingredient from 'aspergillus niger' fungi.

The increasing population, rapidly growing healthcare industry, and consumer awareness regarding joint and bone health is expected to fuel the use of glucosamine in various food & beverage products. In addition, supporting regulatory framework in Europe regarding product use in the manufacturing of food & beverages is expected to propel industry growth over the next seven years. However, an increasing number of substitutes including fish oil and omega-3 may challenge product demand over the forecast period.

Glucosamine Market Report Highlights:

  • The glucosamine sulfate segment accounted for the largest revenue share of 61.1% in 2022. Glucosamine sulfate has been one of the most widely used forms of glucosamine in dietary supplements and pharmaceuticals
  • The glucosamine hydrochloride segment is expected to grow at the second-fastest CAGR of 5.2% over the forecast period. Glucosamine hydrochloride is a compound commonly used as a dietary supplement to support joint health
  • The supplement segment held the largest revenue share of 79.9% in 2022. These supplements are mainly manufactured from crustaceans including shrimp and crabs, however, increasing instances of allergy and a rising number of vegans, particularly in the U.S., have led manufacturers to develop the product from fungi and other plant sources
  • Asia Pacific dominated the market and accounted for the largest revenue share of 47.9% in 2022. The Asia Pacific region, encompassing countries like China, Japan, India, and Australia, boasts a substantial and expanding population, with a simultaneous surge in health and wellness awareness across the area

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Application
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Application outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Glucosamine Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
  • 3.5. Market Dynamics
    • 3.5.1. Market Driver Analysis
    • 3.5.2. Market restraint analysis
    • 3.5.3. Industry opportunities & challenges
  • 3.6. Glucosamines Market Analysis Tools
    • 3.6.1. Industry Analysis - Porter's
      • 3.6.1.1. Supplier power
      • 3.6.1.2. Buyer power
      • 3.6.1.3. Substitution threat
      • 3.6.1.4. Threat of new entrant
      • 3.6.1.5. Competitive rivalry
    • 3.6.2. PESTEL Analysis
      • 3.6.2.1. Political landscape
      • 3.6.2.2. Technological landscape
      • 3.6.2.3. Economic landscape
      • 3.6.2.4. Social landscape
      • 3.6.2.5. Environmental landscape
      • 3.6.2.6. Legal landscape

Chapter 4. Supplier Portfolio Analysis

  • 4.1. List of Suppliers
  • 4.2. Kraljic Matrix
  • 4.3. Sourcing Best Practices
  • 4.4. Negotiation Strategies

Chapter 5. Glucosamine: Product Estimates & Trend Analysis

  • 5.1. Glucosamine Market: Key Takeaways
  • 5.2. Glucosamine Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Glucosamine Sulfate
    • 5.3.1. Glucosamine sulfate market estimates and forecasts, 2018 to 2030 (USD Million, Tons)
  • 5.4. Glucosamine Hydrochloride
    • 5.4.1. Glucosamine hydrochloride market estimates and forecasts, 2018 to 2030 (USD Million, Tons)
  • 5.5. N-acetyl glucosamine
    • 5.5.1. N-acetyl glucosamine market estimates and forecasts, 2018 to 2030 (USD Million, Tons)
  • 5.6. Others
    • 5.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million, Tons)

Chapter 6. Glucosamine: Application Estimates & Trend Analysis

  • 6.1. Glucosamine Market: Key Takeaways
  • 6.2. Glucosamine Market: Movement & Market Share Analysis, 2022 & 2030
  • 6.3. Supplement
    • 6.3.1. Supplement market estimates and forecasts, 2018 to 2030 (USD Million, Tons)
  • 6.4. Food and Beverage
    • 6.4.1. Food and beverage market estimates and forecasts, 2018 to 2030 (USD Million, Tons)
  • 6.5. Others
    • 6.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million, Tons)

Chapter 7. Glucosamine Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Outlook
  • 7.2. Glucosamine Market by Region: Key Takeaway
  • 7.3. North America
    • 7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.4. Mexico
      • 7.3.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4. Europe
    • 7.4.1. Germany
      • 7.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.2. UK
      • 7.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.3. France
      • 7.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.2. China
      • 7.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.3. India
      • 7.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.6. Central & South America
    • 7.6.1. Brazil
      • 7.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.7. MEA
    • 7.7.1. Saudi Arabia
      • 7.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Market Participant Categorization
    • 8.2.1. Koyo Chemical Industry Co., Ltd
      • 8.2.1.1. Company overview
      • 8.2.1.2. Financial performance
      • 8.2.1.3. Product benchmarking
      • 8.2.1.4. Strategic initiatives
    • 8.2.2. Laboratoires Expanscience
      • 8.2.2.1. Company overview
      • 8.2.2.2. Financial performance
      • 8.2.2.3. Product benchmarking
      • 8.2.2.4. Strategic initiatives
    • 8.2.3. Nutramax Laboratories Consumer Care, Inc.
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Product benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. Amway
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Product benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. CELLMARK AB.
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Product benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. Alfa Chemical Group
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Product benchmarking
      • 8.2.6.4. Strategic initiatives
    • 8.2.7. Cargill, Incorporated
      • 8.2.7.1. Company overview
      • 8.2.7.2. Financial performance
      • 8.2.7.3. Product benchmarking
      • 8.2.7.4. Strategic initiatives
    • 8.2.8. Dalian Lijian Bio-Technology Development Co. Ltd
      • 8.2.8.1. Company overview
      • 8.2.8.2. Financial performance
      • 8.2.8.3. Product benchmarking
      • 8.2.8.4. Strategic initiatives
    • 8.2.9. SimplySupplements
      • 8.2.9.1. Company overview
      • 8.2.9.2. Financial performance
      • 8.2.9.3. Product benchmarking
      • 8.2.9.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America Glucosamine Market, By Product, 2018 - 2030 (USD Million, Tons)
  • Table 3 North America Glucosamine Market, By Application, 2018 - 2030 (USD Million, Tons)
  • Table 4 North America Glucosamine Market, By Region, 2018 - 2030 (USD Million, Tons)
  • Table 5 U.S. Glucosamine Market, By Product, 2018 - 2030 (USD Million, Tons)
  • Table 6 U.S. Glucosamine Market, By Application, 2018 - 2030 (USD Million, Tons)
  • Table 7 Canada Glucosamine Market, By Product, 2018 - 2030 (USD Million, Tons)
  • Table 8 Canada Glucosamine Market, By Application, 2018 - 2030 (USD Million, Tons)
  • Table 9 Mexico Glucosamine Market, By Product, 2018 - 2030 (USD Million, Tons)
  • Table 10 Mexico Glucosamine Market, By Application, 2018 - 2030 (USD Million, Tons)
  • Table 11 Europe Glucosamine Market, By Product, 2018 - 2030 (USD Million, Tons)
  • Table 12 Europe Glucosamine Market, By Application, 2018 - 2030 (USD Million, Tons)
  • Table 13 Europe Glucosamine Market, By Region, 2018 - 2030 (USD Million, Tons)
  • Table 14 Germany Glucosamine Market, By Product, 2018 - 2030 (USD Million, Tons)
  • Table 15 Germany Glucosamine Market, By Application, 2018 - 2030 (USD Million, Tons)
  • Table 16 UK Glucosamine Market, By Product, 2018 - 2030 (USD Million, Tons)
  • Table 17 UK Glucosamine Market, By Application, 2018 - 2030 (USD Million, Tons)
  • Table 18 France Glucosamine Market, By Product, 2018 - 2030 (USD Million, Tons)
  • Table 19 France Glucosamine Market, By Application, 2018 - 2030 (USD Million, Tons)
  • Table 20 Italy Glucosamine Market, By Product, 2018 - 2030 (USD Million, Tons)
  • Table 21 Italy Glucosamine Market, By Application, 2018 - 2030 (USD Million, Tons)
  • Table 22 Spain Glucosamine Market, By Product, 2018 - 2030 (USD Million, Tons)
  • Table 23 Spain Glucosamine Market, By Application, 2018 - 2030 (USD Million, Tons)
  • Table 24 Asia Pacific Glucosamine Market, By Product, 2018 - 2030 (USD Million, Tons)
  • Table 25 Asia Pacific Glucosamine Market, By Application, 2018 - 2030 (USD Million, Tons)
  • Table 26 Asia Pacific Glucosamine Market, By Region, 2018 - 2030 (USD Million, Tons)
  • Table 27 China Glucosamine Market, By Product, 2018 - 2030 (USD Million, Tons)
  • Table 28 China Glucosamine Market, By Application, 2018 - 2030 (USD Million, Tons)
  • Table 29 Japan Glucosamine Market, By Product, 2018 - 2030 (USD Million, Tons)
  • Table 30 Japan Glucosamine Market, By Application, 2018 - 2030 (USD Million, Tons)
  • Table 31 India Glucosamine Market, By Product, 2018 - 2030 (USD Million, Tons)
  • Table 32 India Glucosamine Market, By Application, 2018 - 2030 (USD Million, Tons)
  • Table 33 Central & South America Glucosamine Market, By Product, 2018 - 2030 (USD Million, Tons)
  • Table 34 Central & South America Glucosamine Market, By Application, 2018 - 2030 (USD Million, Tons)
  • Table 35 Central & South America Glucosamine Market, By Region, 2018 - 2030 (USD Million, Tons)
  • Table 36 Brazil Glucosamine Market, By Product, 2018 - 2030 (USD Million, Tons)
  • Table 37 Brazil Glucosamine Market, By Application, 2018 - 2030 (USD Million, Tons)
  • Table 38 Middle East and Africa Glucosamine Market, By Product, 2018 - 2030 (USD Million, Tons)
  • Table 39 Middle East and Africa Glucosamine Market, By Application, 2018 - 2030 (USD Million, Tons)
  • Table 40 Middle East and Africa Glucosamine Market, By Region, 2018 - 2030 (USD Million, Tons)
  • Table 41 South Africa Glucosamine Market, By Product, 2018 - 2030 (USD Million, Tons)
  • Table 42 South Africa Glucosamine Market, By Application, 2018 - 2030 (USD Million, Tons)
  • Table 43 Saudi Arabia Glucosamine Market, By Product, 2018 - 2030 (USD Million, Tons)
  • Table 44 Saudi Arabia Glucosamine Market, By Application, 2018 - 2030 (USD Million, Tons)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Glucosamine: Market outlook
  • Fig. 9 Glucosamine: Competitive Insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Glucosamine market driver impact
  • Fig. 15 Glucosamine market restraint impact
  • Fig. 16 Glucosamine Market Strategic Initiatives Analysis
  • Fig. 17 Glucosamine market: Product movement analysis
  • Fig. 18 Glucosamine market: Product outlook and key takeaways
  • Fig. 19 Glucosamine sulfate market estimates and forecasts, 2018 - 2030
  • Fig. 20 Glucosamine hydrochloride market estimates and forecasts, 2018 - 2030
  • Fig. 21 N-acetyl glucosamine market estimates and forecasts, 2018 - 2030
  • Fig. 22 Others glucosamine market estimates and forecasts, 2018 - 2030
  • Fig. 23 Glucosamine market: Application movement analysis
  • Fig. 24 Glucosamine market: Application outlook and key takeaways
  • Fig. 25 Supplement market estimates and forecasts, 2018 - 2030
  • Fig. 26 Food and beverage market estimates and forecasts, 2018 - 2030
  • Fig. 27 Others market estimates and forecasts, 2018 - 2030
  • Fig. 28 Global glucosamine market: Regional movement analysis
  • Fig. 29 Global glucosamine market: Regional outlook and key takeaways
  • Fig. 30 North America market estimates and forecasts, 2018 - 2030
  • Fig. 31 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 32 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 33 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 34 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 35 UK market estimates and forecasts, 2018 - 2030
  • Fig. 36 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 37 France market estimates and forecasts, 2018 - 2030
  • Fig. 38 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 39 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 40 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 41 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 42 China market estimates and forecasts, 2018 - 2030
  • Fig. 43 India market estimates and forecasts, 2018 - 2030
  • Fig. 44 Central & South America market estimates and forecasts, 2018 - 2030
  • Fig. 45 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 46 Middle East and Africa. market estimates and forecasts, 2018 - 2030
  • Fig. 47 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 48 South Africa market estimates and forecasts, 2018 - 2030